Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Camphene SCHEMBL14763794 | 1.00 | CNR2 (0.42) | CNR2 | |
| (-)-Camphene SCHEMBL6552600 | 1.00 | CNR2 (0.42) | CNR2 | |
| Camphene SCHEMBL1869438 | 1.00 | CNR2 (0.42) | CNR2 | |
| (-)-Camphene SCHEMBL8819262 | 1.00 | CNR2 (0.42) | CNR2 | |
| Camphene SCHEMBL8921 | 1.00 | CNR2 (0.42) | CNR2 | |
| Camphene SCHEMBL1244388 | 0.98 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL9803985 | 0.98 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL31057504 | 0.98 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL31305341 | 0.98 | CNR2 (0.41) | CNR2 | |
| Camphene SCHEMBL2370360 | 0.98 | CNR2 (0.41) | CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12635710-B2 | Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions | EASTMAN CHEMICAL COMPANY (US) | 2026-05-26 | — | — | US | claimed |
| US-20240215608-A1 | METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 2024-07-04 | — | — | US | claimed |
| EP-4319559-A1 | METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS | Eastman Chemical Company (US) | 2024-02-14 | — | — | EP | claimed |
| CN-117222327-A | Methods of using formaldehyde-free antimicrobial compositions in animal byproduct compositions | 伊士曼化工公司 | 2023-12-12 | — | — | CN | claimed |
| EP-4229639-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS Global Biopharma, Inc. (CA) | 2023-08-23 | — | — | EP | claimed |
| WO-2022217031-A1 | METHODS OF USING FORMALDEHYDE-FREE ANTIMICROBIAL COMPOSITIONS IN ANIMAL BY-PRODUCT COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 2022-10-13 | — | — | WO | claimed |
| US-11434448-B2 | Perfume compositions | GIVAUDAN S.A. (CH) | 2022-09-06 | — | — | US | claimed |
| US-11424006-B2 | Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide | PSOMAGEN, INC. (US) | 2022-08-23 | — | — | US | claimed |
| EP-4040979-A1 | ANTIMICROBIAL COMPOSITION FOR ANIMAL FEED | Taminco BV (BE) | 2022-08-17 | — | — | EP | claimed |
| CN-114513960-A | Antimicrobial composition for animal feed | 塔明克私人有限公司 | 2022-05-17 | — | — | CN | claimed |
| WO-2022081889-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS GLOBAL BIOPHARMA, INC. (CA) | 2022-04-21 | — | — | WO | claimed |
| US-20210040415-A1 | PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2021-02-11 | — | — | US | claimed |
| EP-3668494-A1 | TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE | Psomagen, Inc. (US) | 2020-06-24 | — | — | EP | claimed |
| WO-2019036507-A1 | TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE | uBiome, Inc. (US) | 2019-02-21 | — | — | WO | claimed |
| US-12635710-B2 | Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions | EASTMAN CHEMICAL COMPANY (US) | 2026-05-26 | — | — | US | disclosed |
| CN-122055056-A | Herbicidal compositions based on monoterpene compounds and diterpene compounds | 拜奥布莱斯特有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4702036-A1 | METHOD OF PRODUCING TERPENES | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| US-6486115-B1 | Microemulsion cleaning composition | BAKER HUGHES INCORPORATED | 2002-11-26 | — | — | US | disclosed |
| EP-1228189-A1 | MICROEMULSION CLEANING COMPOSITION | BAKER HUGHES INCORPORATED (US) | 2002-08-07 | — | — | EP | disclosed |
| WO-2001034760-A1 | MICROEMULSION CLEANING COMPOSITION | BAKER HUGHES INCORPORATED (US) | 2001-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11424006-B2 | Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide | PNMT, MAOA, HNMT | CNR2 1064/4885 |
| US-12635710-B2 | Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions | FABP2, FABP1, VIP | CNR2 4000/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.